Tracking cancer drugs in living cells by thermal profiling of the proteome
- PMID: 25278616
- DOI: 10.1126/science.1255784
Tracking cancer drugs in living cells by thermal profiling of the proteome
Abstract
The thermal stability of proteins can be used to assess ligand binding in living cells. We have generalized this concept by determining the thermal profiles of more than 7000 proteins in human cells by means of mass spectrometry. Monitoring the effects of small-molecule ligands on the profiles delineated more than 50 targets for the kinase inhibitor staurosporine. We identified the heme biosynthesis enzyme ferrochelatase as a target of kinase inhibitors and suggest that its inhibition causes the phototoxicity observed with vemurafenib and alectinib. Thermal shifts were also observed for downstream effectors of drug treatment. In live cells, dasatinib induced shifts in BCR-ABL pathway proteins, including CRK/CRKL. Thermal proteome profiling provides an unbiased measure of drug-target engagement and facilitates identification of markers for drug efficacy and toxicity.
Copyright © 2014, American Association for the Advancement of Science.
Similar articles
-
Thermal proteome profiling monitors ligand interactions with cellular membrane proteins.Nat Methods. 2015 Dec;12(12):1129-31. doi: 10.1038/nmeth.3652. Epub 2015 Nov 2. Nat Methods. 2015. PMID: 26524241
-
Cell-based proteome profiling of potential dasatinib targets by use of affinity-based probes.J Am Chem Soc. 2012 Feb 15;134(6):3001-14. doi: 10.1021/ja208518u. Epub 2012 Feb 1. J Am Chem Soc. 2012. PMID: 22242683
-
Nonparametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-binding Proteins.Mol Cell Proteomics. 2019 Dec;18(12):2506-2515. doi: 10.1074/mcp.TIR119.001481. Epub 2019 Oct 3. Mol Cell Proteomics. 2019. PMID: 31582558 Free PMC article.
-
Membrane proteomics for leukemia classification and drug target identification.Curr Opin Mol Ther. 2009 Dec;11(6):603-10. Curr Opin Mol Ther. 2009. PMID: 20072937 Review.
-
Emerging Methods in Chemoproteomics with Relevance to Drug Discovery.Methods Mol Biol. 2017;1513:11-22. doi: 10.1007/978-1-4939-6539-7_2. Methods Mol Biol. 2017. PMID: 27807827 Review.
Cited by
-
System-wide identification and prioritization of enzyme substrates by thermal analysis.Nat Commun. 2021 Feb 26;12(1):1296. doi: 10.1038/s41467-021-21540-6. Nat Commun. 2021. PMID: 33637753 Free PMC article.
-
A mass spectrometry-based proteome map of drug action in lung cancer cell lines.Nat Chem Biol. 2020 Oct;16(10):1111-1119. doi: 10.1038/s41589-020-0572-3. Epub 2020 Jul 20. Nat Chem Biol. 2020. PMID: 32690943
-
Proteomic characterization of post-translational modifications in drug discovery.Acta Pharmacol Sin. 2022 Dec;43(12):3112-3129. doi: 10.1038/s41401-022-01017-y. Epub 2022 Nov 13. Acta Pharmacol Sin. 2022. PMID: 36372853 Free PMC article. Review.
-
System-Wide Profiling by Proteome Integral Solubility Alteration Assay of Drug Residence Times for Target Characterization.Anal Chem. 2022 Nov 15;94(45):15772-15780. doi: 10.1021/acs.analchem.2c03506. Epub 2022 Nov 3. Anal Chem. 2022. PMID: 36377428 Free PMC article.
-
Drug mechanism-of-action discovery through the integration of pharmacological and CRISPR screens.Mol Syst Biol. 2020 Jul;16(7):e9405. doi: 10.15252/msb.20199405. Mol Syst Biol. 2020. PMID: 32627965 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous